COV.V : Summary for COVALON TECHNOLOGIES LTD - Yahoo Finance

U.S. Markets closed

Covalon Technologies Ltd. (COV.V)


TSXV - TSXV Delayed Price. Currency in CAD
Add to watchlist
2.010.00 (0.00%)
At close: 3:59PM EDT
People also watch
CZO.VRX.VHTL.VMBX.TOCOT.V
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close2.01
Open2.01
Bid2.01 x
Ask2.10 x
Day's Range2.01 - 2.10
52 Week Range0.84 - 2.85
Volume3,744
Avg. Volume11,806
Market Cap38.94M
Beta1.02
PE Ratio (TTM)-10.31
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Covalon Technologies Ltd. :COV-CA: Earnings Analysis: Q1, 2017 By the Numbers : March 8, 2017
    Capital Cube18 days ago

    Covalon Technologies Ltd. :COV-CA: Earnings Analysis: Q1, 2017 By the Numbers : March 8, 2017

    Categories: Yahoo Finance Get free summary analysis Covalon Technologies Ltd. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Covalon Technologies Ltd. – Ergoresearch Ltd., Pyng Medical Corp. and Novadaq Technologies Inc. (ERG-CA, PYT-CA and NVDQ-US) that have also reported for this period. Highlights Summary numbers: Revenues ... Read more (Read more...)

  • Business Wirelast month

    Covalon Announces Issuance of Stock Options

    Covalon Technologies Ltd. , an advanced medical technologies company, today announced the issuance of an aggregate of 265,000 stock options to employees and consultants of the Company.

  • Business Wire2 months ago

    Covalon Posts Record First Quarter Financial Results

    Covalon Technologies Ltd. , an advanced medical technologies company, announced today record first quarter financial results, which included revenue of $5,608,927 and profit of $543,110 or $0.03 per share for the three months ended December 31, 2016.